Monday, 24th January 2022

Being the only and the largest healthcare body in the US, Medicare provides health benefits to people aged 65 or more. As the enrolment period approaches, there is quite a buzz around the Americans due to the availability of new plans, changes, and reduced premiums. Nevertheless, the hot piping news revolving around Medicare and health insurance are as follows for today:

Mental Healthcare System

According to one report earlier today, gaps have been observed in the US healthcare system. Compared to other affluent nations, the US healthcare system has fewer provisions for mental health, and the costs are so high that many insurers forego the idea of getting treatment for mental health. 

Indeed, there are mental health screenings and counseling services. However, it doesn’t suffice for the growing need for healthcare treatment. According to the statistics in the report, several people get mental health diagnoses in the US, but they don’t go for treatment due to high healthcare costs. 

In other healthcare nations such as the UK and France, the cost isn’t a normally cited issue, and only about 10% of the people may forego treatment due to cost. The US mental health coverage gap is due to the lack of facilities and traditional policies that don’t allow people to get access to healthcare.

For example, Medicare has a policy covering 190 inpatient psychiatric treatments. Secondly, prescription drug costs are too high, increasing out-of-pocket costs, causing people to avoid getting mental health treatment. The report suggested that the system investigate the issue and maybe adopt policies from other nations with well-regulated mental health provisions.

Insurers are paying for ivermectin to treat COVID.

Despite being a drug to treat parasite infections, insurers in the US use ivermectin to treat COVID. Not only that, but several people are also using it in place of vaccination. However, no evidence suggests that the drug can reduce COVID infections. 

Due to such issues, there is a strain on insurance companies which are paying about 61% of the drug cost; i.e., $40. The only way for resolving such an issue can be strict prescription and form authorization that restricts people from purchasing it. 


That was the most interesting news in the Medicare sector for today. Visit our website to learn more about Medicare and the open enrolment period.